Home »
Researchers have identified a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients, which they hope could serve as a biomarker to select patients to receive targeted therapy. Triple-negative breast cancer (TNBC) is
Surgery offers the best chance of a cure for patients with early cancer and is fundamental to cancer management, but it does not receive enough political and financial recognition, warns a European expert. In addition,
The debilitating arm and shoulder disability and pain that some women who have had breast cancer surgery experience as a side effect of their surgery can be reduced by following a physiotherapy-led exercise programme after
Writing in EMBO reports, researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health describe how a pair of fundamental genetic and cellular processes are exploited
Care for the 15 most prevalent types of cancer in the U.S. cost approximately $156.2 billion in 2018, according to a team of Penn State College of Medicine researchers. The team also found that medication
New research in the October 2021 issue of JNCCN—Journal of the National Comprehensive Cancer Network assessed patient satisfaction and preferences for telemedicine, finding 45% of people with cancer preferred telemedicine, while 34% preferred office visits,
When Hispanic people get a skin cancer diagnosis, their tumors are about 17% larger than those of white people, researchers say. According to the American Academy of Dermatology (AAD), skin cancer is often diagnosed at
(HealthDay)—A direct-to-consumer machine learning model for detecting skin cancers may not adequately recognize rare, but aggressive, skin cancers, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology,
It's rare for young women to be diagnosed with breast cancer. "It's still 5 to 6 percent of all incidence for someone under the age of 40," says Dorraya El-Ashry, chief scientific officer of the
An especially deadly subtype of T-cell lymphoma is distinguished by unique mutations in a specific protein signaling pathway, according to a study published in the journal Blood. Correcting the downstream effect of these mutations with